Literature DB >> 15122797

IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba.

Ana B Pérez1, Gissel García, Beatriz Sierra, Mayling Alvarez, Susana Vázquez, María V Cabrera, Rosmary Rodríguez, Delfina Rosario, Eric Martínez, Thomas Denny, María G Guzmán.   

Abstract

The pathogenesis associated with Dengue haemorrhagic fever, has yet to be fully elucidated, with no definitive in vivo evidence. The exceptional epidemiological circumstances in Cuba allow the evaluation of different mediators in a well-defined situation. In the present study, we describe the determination of levels of IL-12, IL-10 and RANTES in the sera of Cuban patients hospitalised with Dengue fever or Dengue haemorrhagic fever. The results showed that levels of serum IL-10 were higher in patients than controls, and those patients with secondary infections had consistently higher levels. All the Dengue haemorrhagic fever patients had increased levels of IL-10. In contrast, levels of IL-12 did not differ between patients and controls. Finally, RANTES serum levels detected in patients were lower than those observed in the controls. The association of increased levels of IL-10 in Dengue patients with a sequential infection suggests a possible role of this cytokine in the pathogenesis of Dengue disease. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122797     DOI: 10.1002/jmv.20080

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  48 in total

1.  A three-component biomarker panel for prediction of dengue hemorrhagic fever.

Authors:  Allan R Brasier; Hyunsu Ju; Josefina Garcia; Heidi M Spratt; Sundar S Victor; Brett M Forshey; Eric S Halsey; Guillermo Comach; Gloria Sierra; Patrick J Blair; Claudio Rocha; Amy C Morrison; Thomas W Scott; Isabel Bazan; Tadeusz J Kochel
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 3.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

4.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

5.  Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.

Authors:  Ruklanthi de Alwis; Derek J Bangs; Michael A Angelo; Cristhiam Cerpas; Anira Fernando; John Sidney; Bjoern Peters; Lionel Gresh; Angel Balmaseda; Aruna D de Silva; Eva Harris; Alessandro Sette; Daniela Weiskopf
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

6.  Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever.

Authors:  Allan R Brasier; Josefina Garcia; John E Wiktorowicz; Heidi M Spratt; Guillermo Comach; Hyunsu Ju; Adrian Recinos; Kizhake Soman; Brett M Forshey; Eric S Halsey; Patrick J Blair; Claudio Rocha; Isabel Bazan; Sundar S Victor; Zheng Wu; Susan Stafford; Douglas Watts; Amy C Morrison; Thomas W Scott; Tadeusz J Kochel
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

7.  Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever.

Authors:  Ana Saksida; Darja Duh; Branka Wraber; Isuf Dedushaj; Salih Ahmeti; Tatjana Avsic-Zupanc
Journal:  Clin Vaccine Immunol       Date:  2010-05-19

8.  The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability.

Authors:  Henry Puerta-Guardo; Arturo Raya-Sandino; Lorenza González-Mariscal; Victor H Rosales; José Ayala-Dávila; Bibiana Chávez-Mungía; Daniel Martínez-Fong; Fernando Medina; Juan E Ludert; Rosa María del Angel
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Authors:  Scott J Balsitis; Katherine L Williams; Ruben Lachica; Diana Flores; Jennifer L Kyle; Erin Mehlhop; Syd Johnson; Michael S Diamond; P Robert Beatty; Eva Harris
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

Review 10.  The relationship of interacting immunological components in dengue pathogenesis.

Authors:  David G Nielsen
Journal:  Virol J       Date:  2009-11-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.